A detailed history of Prelude Capital Management, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Prelude Capital Management, LLC holds 4,081 shares of MDT stock, worth $368,065. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,081
Previous 4,081 -0.0%
Holding current value
$368,065
Previous $367,000 -0.0%
% of portfolio
0.02%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.84 - $91.03 $313,584 - $371,493
4,081 New
4,081 $367,000
Q1 2024

May 15, 2024

BUY
$82.84 - $88.09 $3.81 Million - $4.05 Million
45,942 New
45,942 $4 Million
Q2 2022

Aug 15, 2022

BUY
$87.4 - $113.09 $627,619 - $812,099
7,181 New
7,181 $644,000
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $1.21 Million - $1.35 Million
-12,029 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $506,010 - $649,481
5,084 Added 73.2%
12,029 $1.24 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $479,584 - $528,109
3,907 Added 128.6%
6,945 $871,000
Q2 2021

Aug 16, 2021

BUY
$118.19 - $131.5 $318,403 - $354,261
2,694 Added 783.14%
3,038 $377,000
Q4 2019

Feb 14, 2020

SELL
$104.49 - $114.54 $166,243 - $182,233
-1,591 Reduced 82.22%
344 $39,000
Q3 2019

Nov 14, 2019

SELL
$98.02 - $111.18 $119,878 - $135,973
-1,223 Reduced 38.73%
1,935 $210,000
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $1.28 Million - $1.51 Million
-15,210 Reduced 82.81%
3,158 $308,000
Q1 2019

May 15, 2019

SELL
$82.45 - $93.79 $360,883 - $410,518
-4,377 Reduced 19.24%
18,368 $1.67 Million
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $1.54 Million - $1.79 Million
17,960 Added 375.34%
22,745 $2.07 Million
Q3 2018

Nov 14, 2018

BUY
$85.91 - $99.17 $97,507 - $112,557
1,135 Added 31.1%
4,785 $471,000
Q2 2018

Aug 14, 2018

BUY
$77.48 - $87.83 $282,802 - $320,579
3,650 New
3,650 $312,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.